Bessent soothes bond market with Treasury repurchases
US Treasury Secretary Scott Bessent announced a bond repurchase program, doubling buybacks for 10- to 30-year Treasuries, calming bond markets and leading to a rally in Wall Street stocks. Moderna surged 156% after successful melanoma treatment trials with Merck & Co's Keytruda. SpaceX declined 3.4% amid reports of a potential acquisition of Cognition AI. Bitcoin rose 5.8% to $68,380 as Trump pushed for digital asset legislation.
How this was made
The 30-second read
Why it matters
The Treasury repurchase announcement calmed bond yields, while multiple corporate catalysts drove equity gains across sectors.
Market read
Broad market rally driven by Treasury action and strong corporate news; crypto gains on policy support.
What to watch
Potential regulatory scrutiny on large Treasury repurchases and the sustainability of biotech trial hype.
Background
Morning market wrap covering Treasury liquidity program, AI sector moves, biotech trial news, and crypto policy.
Ticker impact
Moderna stock surged 156% after positive melanoma trial results with Merck's Keytruda.
Continued rally expected on follow‑on coverage and potential partnership expansion.
Phase‑2 data with clear clinical benefit and a major pharma partner signals material upside.
Merck shares jumped 13% as its Keytruda partnership with Moderna was highlighted in the trial news.
Likely short‑term upside as investors reassess Merck's growth prospects.
Partner trial success can lift Merck's stock but broader market factors remain.
Marvell Technology rose after signing an agreement with Alphabet's Google for a $12.2 bn share‑buy arrangement.
Potential near‑term rally as the market prices the cash infusion.
Large strategic investment from Google is a material catalyst.
Target beat earnings expectations, contributing to the S&P 500 gain.
Modest upside expected on continued earnings strength.
Standard earnings beat; limited new information beyond expectations.
Bitcoin rose 5.8% to $68,380 after President Trump advocated for a digital‑asset market‑structure law.
Short‑term rally likely; longer‑term impact depends on legislative outcome.
Regulatory endorsement is a fresh catalyst for crypto markets.
Market effects
Biotech and oncology sectors gain from Moderna/Merck trial; semiconductor sector benefits from Marvell‑Google deal.
US equity markets rallied; Australian futures show modest gains.
Treasury repurchase program supports bond market stability worldwide.
Counterpoint
The Treasury buyback may be a temporary fix; underlying inflation pressures could still weigh on bonds.
Key entities
- personScott Bessent
U.S. Treasury Secretary overseeing bond repurchase program
- companyModerna
Biotech firm reporting melanoma trial results
- companyMerck & Co
Pharma partner in the melanoma trial
